Clinical Trial Update: S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 SWOG trial S0215 evaluated a four-drug regimen of trastuzumab, docetaxel, vinorelbine, and filgrastim in women with stage IV breast cancer. The trial ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)
• Navelbine (vinorelbine)
• Neupogen (Filgrastim)
• Taxotere (docetaxel)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-06-06